Get started

AARTIDRUGS

Aarti Drugs - Key Levels to WatchAarti Drugs - Key Levels to Watch 🔍 Aarti Drugs has shown some recovery after restoring production at its Tarapur unit, as per recent filings. Here’s the technical outlook: 1.Fibonacci Retracement Levels: Resistance at 0.618 (₹593) and 0.5 (₹676). Immediate support near 0.786 (₹476). 2.Volume Profile: High activity seen between ₹450-₹500. Sustained support in this zone is crucial. 3.RSI: Current RSI shows a slight bullish divergence—monitor for a potential rebound. Levels of Interest: Upside Potential: ₹593 (618 Fib) and ₹676 (0.5 Fib). Downside Support: ₹476 (786 Fib) and ₹450 (volume support zone). Stay cautious as the stock consolidates. Monitor for clear directional moves above or below these levels.
NSE:AARTIDRUGS
by AngshumanSaikia
Aarti Drugs giving signs of pennant Breakout. Aarti Drugs Limited (ADL) is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. ADL engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India geographical segments. Aarti Drugs Limited (ADL) CMP is 495.70. The positive aspects of the company are Company with Low Debt, Growth in Quarterly Net Profit with increasing Profit Margin, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding, and Mutual Funds Increased Shareholding. The Negative aspects of the company are Decline in Quarterly Net Profit, MFs decreased their shareholding last quarter and Promoter decreasing their shareholding. Entry can be taken after closing above 503 Targets in the stock will be 519 and 531. The long-term target in the stock will be 549 and 568. Stop loss in the stock should be maintained at Closing below 456. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:AARTIDRUGSLong
by Happy_Candles_Investment
#JUBLPHARMA 435 TGT 590 SL 400 Buy Recommended - Rachit SethiaJUBLPHARMA 435 Target 590 SL 400 Return 43% RR > 4.5 TF < 6 Months Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk Return Ratio is healthy. And Rising from Double Bottom Pattern to Flag Pattern forming. If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations. With 💚 from Rachit Sethia
NSE:JUBLPHARMALong
by Rachit_Sethia
Wave 3 in AARTIDRUGS can push price up by 80%!!The Stock witnessed a five-wave impulsive rise beginning in March 2023 and ending in July 2023. The impulse move led to a 105% rally in the stock in a matter of just 5 months. Since the completion of the wave 1 in July however, the stock went into the corrective wave 2 structure between July-October. The corrective phase can be marked as an Elliot wave Zig-zag(ABC) and led to a 50% retracement of the wave 1. This phase ended in October and between October-November the stock displayed a slow moving leading diagonal as the first sign of reversal from the bottom of INR 444.This tiny diagonal is the only starting piece of the massive leg that is yet to unfold in the stock, taking it towards the INR 900 mark. The diagonal and its correction can be labeled as wave i&ii of 3 respectively and now the stock has "jump-started" the wave iii of 3 on 18DEC with a +4.2% closing alongside uptick in volumes. Upon successfully surpassing INR500 level, the stock shall be at the INR550 in 'very quick move'. INR 900 is the projected target region for the Wave 3. On the downside INR 470 can be used as 'SL'. Note*- The views expressed are based on personal opinions and observations. Please do your own research before making any trading/investing decisions.
NSE:AARTIDRUGSLong
by neeraj_2_sharma
Aarti Drugs looking to dazzleAarti drugs limited is a pharmaceutical & biotechnology company engaged in manufacturing of APIs (Active Pharmaceutical Ingredients), Pharma Intermediates & Specialty chemicals. With strong Research and Development (R&D) and GMP certified manufacturing units the company aims to provide quality and effective solutions to their clients PAN India. CMP of the stock is 457.80. Negative of the company is declining annual net profit. Positives of the company are low debt, improving quarterly net profit and FIIs and MFs are increasing stake. Entry in the stock can be taken after closing above 471. Target will be 512 & 531. Long term target will be 600+. Stop loss in the stock should be kept at the closing below 396.
NSE:AARTIDRUGSLong
by Happy_Candles_Investment
#GUFICBIO #ZYDUSWELL #FORTIS #AARTIDRUGS #ALKEM #GLAND #BIOCON #GUFICBIO NSE: GUFICBIO CMP: 227 TP: 270 SL: 205 TF: <6m RR > ~2 times Return > 18% GUFICBIO THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk Return Ratio is healthy. And Rising from Double Bottom Pattern to Flag Pattern forming. If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations. With 💚 from Rachit Sethia
NSE:GUFICBIOLong
by Rachit_Sethia
#LALPATHLAB #MOREPENLAB #IPCALAB #DIVISLAB #VIMTALAB #LAURUSLABS#LALPATHLAB NSE: LALPATHLAB CMP: 2345 TP: 3075 SL: 2100 TF: <6m RR > ~3 times Return > 30% THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk Return Ratio is healthy. And Rising from Double Bottom Pattern to Flag Pattern forming.
NSE:LALPATHLABLong
by Rachit_Sethia
Aarti Drugs Dares To Move Up. X/2 Entry in Aarti Drugs can be taken after closing above 467 and second X/2 entry can be taken after closing above 475. Targets will be 489 and 510. Long term target in the company will be 531. Stop loss in the company can be maintained at a closing below 440. Aarti Drugs Ltd. is a manufacturer of APIs Pharma intermediates and specialty chemicals. Negative of Aarti Drugs are that they have declining net profits. Positives are such that they have Zero Promoter Pledge, Increasing Net Profit, FIIs are increasing stake and have Improving Cash Flow.
NSE:AARTIDRUGSLong
by Happy_Candles_Investment
Aarti Drug time If we look at this chart, it tries to break the Bollinger band two times within 110 days; even we look at the past, it was unable to break. But now you can see the last three days it closes almost above the upper resistance of BB, i.e. (mean + 2* Standard Deviation). Bollinger Band, In mathematics, we called it Gaussian or normal distribution or bell curve. If we notice the MACD is positive, and Histogram shows its strength is continuously increasing. RSI is also above 60, and today's it 71.15, and the interesting fact is it tries to reverse but again ready to go up. If we notice today's close price (813.6), it also breaks the resistance that was 811pts and might be a support for this month. All those four signs indicate that the rally has begun for aarti drug. In Fluid Mechanics, we called when the flow tries to contract (Squeezing the BB from last 4 to 5 months), the pipe will burst, and due to sudden expansion and that flow will be uncontrolled flow. Disclaimer, This analysis only for study purposes. Do your own study before any call. I'm not a Sebi register. All trading strategies are used at your own risk.
NSE:AARTIDRUGS
by Narayan_Das